Chronic myelogenous leukemia: a 22-year survival

Area of Science:

• Hematology
• Oncology
• Leukemia Research

Background:

• Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm.
• Standard treatments include targeted therapies and chemotherapy.
• This case explores an alternative therapeutic approach in CML management.

Observation:

• A 25-year-old woman diagnosed with CML presented with classic symptoms.
• Initial treatment involved splenic irradiation for 15 months.
• Subsequent busulfan therapy was administered due to rising blood counts, leading to severe thrombocytopenia.

Findings:

• The patient achieved a complete remission of CML.
• Remission has been sustained for 17 years without any ongoing therapy.
• Bone marrow examinations and chromosome studies have remained normal throughout the remission period.

Implications:

• This case suggests the possibility of long-term, durable remissions in CML, even after complex treatment histories.
• It underscores the importance of long-term patient follow-up in understanding leukemia trajectories.
• Further research into mechanisms of sustained remission in CML may offer new therapeutic insights.